In bladder cancer patients, Yan, B. et al. observed that GLUT3 influences the stability of YTHDC1 by promoting the expression of RNF183, thereby playing a pivotal role in the regulation of both glucose metabolism and the progression of bladder cancer [16]. Here, SLC2A3 is linked to urinary bladder cancer.